MiR-181b: new perspective to evaluate disease progression in chronic lymphocytic leukemia

Over the past decades numerous markers of the tumor burden have been discovered in chronic lymphocytic leukemia (CLL). Among these, the microRNAs seem to have a promising role. The development and validation of miRNAs as biomarkers should have significant impact in improving early cancer detection a...

Descripción completa

Detalles Bibliográficos
Autores principales: Visone, Rosa, Veronese, Angelo, Balatti, Veronica, Croce, Carlo M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2012
Materias:
Research Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326649/
https://www.ncbi.nlm.nih.gov/pubmed/22350310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326649/
https://www.ncbi.nlm.nih.gov/pubmed/22350310

Ejemplares similares